Source: Molecular Neurobiology. Unidades: FMRP, FCFRP, FORP
Subjects: METABOLÔMICA, DOENÇA DE PARKINSON, DISCINESIAS, FÁRMACOS (SISTEMA NERVOSO CENTRAL)
ABNT
SANTOS-LOBATO, Bruno L. et al. Metabolic profile in plasma and CSF of LEVODOPA-induced dyskinesia in Parkinson’s disease: focus on neuroinflammation. Molecular Neurobiology, v. 59, n. 2, p. 1140-1150, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12035-021-02625-1. Acesso em: 14 nov. 2024.APA
Santos-Lobato, B. L., Gardinassi, L. G., Bortolanza, M., Peti, A. P. F., Pimentel, Â. V., Faccioli, L. H., et al. (2022). Metabolic profile in plasma and CSF of LEVODOPA-induced dyskinesia in Parkinson’s disease: focus on neuroinflammation. Molecular Neurobiology, 59( 2), 1140-1150. doi:10.1007/s12035-021-02625-1NLM
Santos-Lobato BL, Gardinassi LG, Bortolanza M, Peti APF, Pimentel ÂV, Faccioli LH, Del Bel EA, Tumas V. Metabolic profile in plasma and CSF of LEVODOPA-induced dyskinesia in Parkinson’s disease: focus on neuroinflammation [Internet]. Molecular Neurobiology. 2022 ; 59( 2): 1140-1150.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s12035-021-02625-1Vancouver
Santos-Lobato BL, Gardinassi LG, Bortolanza M, Peti APF, Pimentel ÂV, Faccioli LH, Del Bel EA, Tumas V. Metabolic profile in plasma and CSF of LEVODOPA-induced dyskinesia in Parkinson’s disease: focus on neuroinflammation [Internet]. Molecular Neurobiology. 2022 ; 59( 2): 1140-1150.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s12035-021-02625-1